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ABSTRACT
Rad26p, a yeast homologue of human Cockayne
syndrome B with an ATPase activity, plays a
pivotal role in stimulating DNA repair at the coding
sequences of active genes. On the other hand,
DNA repair at inactive genes or silent areas of
the genome is not regulated by Rad26p. However,
how Rad26p recognizes DNA lesions at the actively
transcribing genes to facilitate DNA repair is not
clearly understood in vivo. Here, we show that
Rad26p associates with the coding sequences
of genes in a transcription-dependent manner,
but independently of DNA lesions induced
by 4-nitroquinoline-1-oxide in Saccharomyces
cerevisiae. Further, histone H3 lysine 36 methylation
that occurs at the active coding sequence
stimulates the recruitment of Rad26p. Intriguingly,
we find that Rad26p is recruited to the site of DNA
lesion in an elongating RNA polymerase
II-dependent manner. However, Rad26p does not
recognize DNA lesions in the absence of active
transcription. Together, these results provide an
important insight as to how Rad26p is delivered to
the damage sites at the active, but not inactive,
genes to stimulate repair in vivo, shedding much
light on the early steps of transcription-coupled
repair in living eukaryotic cells.
INTRODUCTION
Genomic DNA is continuously challenged by a variety of
damaging agents which can be of either exogenous or
endogenous origin (1,2). The deﬁciencies in repairing
DNA lesions are fundamental to the etiology of most
cancers (2–11). However, a cell employs a number of
repair pathways to maintain its genomic stability (7–30).
One such repair mechanism utilized by the cell is nucleo-
tide excision repair (NER). NER removes a wide variety
of DNA lesions including UV-induced pyrimidine dimers
(cyclobutane pyrimidine dimers and 6-4 photoproducts)
and DNA-helix distorting bulky chemical adducts
[e.g. 4-nitroquinoline-1-oxide (4NQO) adduct], and thus,
is the most ﬂexible DNA repair pathway. It is a complex
process that requires stepwise action of many proteins
for damage recognition, local opening of DNA duplex
around the lesion, dual incision of the damaged DNA
strand, gap repair synthesis and strand ligation
(1,2,8,13,15–17,19,24,25).
Signiﬁcant insight was gained in human NER through
the study of two autosomal recessive disorders, namely
xeroderma pigmentosum (XP) and Cockayne syndrome
(CS). The patients with either one of these disorders
show severe UV hypersensitivity. XP disorder is caused
by mutation in one of the seven genes (i.e. XPA, XPB,
XPC, XPD, XPE, XPF and XPG), while the defect in
the CSA or CSB gene leads to CS disease. The XP gene
products perform various functions during damage recog-
nition, DNA unwinding and incision (11,15–19,25). For
example, XPC (Rad4p in yeast)/HHR23B (Rad23p in
yeast) initially detects DNA lesion (19), and subsequently,
XPA (Rad14p in yeast) and heterotrimeric replication
protein A (RPA) bind to the site of DNA lesion to
further aid in damage recognition. The XPB (Rad25p in
yeast) and XPD (Rad3p in yeast) helicases (components of
transcription factor, TFIIH) then unwind duplex DNA in
the vicinity of lesion followed by XPG (Rad2p in yeast)
and ERCC1 (Rad10p in yeast)/XPF (Rad1p in yeast)
endonuclease-mediated incision of one strand of DNA
at positions 30 and 50 to the damage, respectively, generat-
ing  30 base oligonucleotide containing lesion. On the
other hand, the CS gene products participate in the
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genes (2,14,20–24,27,30). Thus, NER removes DNA
lesion from the active and inactive genes. Accordingly,
NER has been classiﬁed into two types, namely global
genomic NER (GG-NER) and transcription-coupled
NER (TC-NER). The DNA lesions in the transcription-
ally inactive or silent areas of the genome are repaired by
GG-NER pathway (17,19,24,25). The TC-NER process
repairs DNA lesions at the coding sequence of the
transcriptionally active gene (8,17,24,26–40).
Both the subpathways of NER are fundamentally iden-
tical except their mechanisms of damage recognition.
Interestingly, TC-NER functions at a much faster rate
than GG-NER (8,17,24,26–40) as damage is promptly
recognized in TC-NER. In GG-NER, the XPC/
HHR23B participates in initial recognition of DNA
lesions (15,19,25,40). However, the recognition of the
damaged DNA during TC-NER does not require XPC
(14,17,24,33,37,40). In TC-NER, the transcription elonga-
tion machinery stalls at the site of DNA lesion
(24,31,32,36,38,41–46), and subsequently, elongating
RNA polymerase II is disassembled through speciﬁc deg-
radation of its largest subunit (47). Such a disassembly of
RNA polymerase II has been proposed to allow the
TC-NER-speciﬁc proteins such as CSA and CSB to gain
access to the damaged DNA (14,38,40,43,48,49).
However, how TC-NER-speciﬁc factors are recruited to
the site of DNA lesion at the active gene in eukaryotes
remains unknown in vivo. Here, primarily using a
formaldehyde-based in vivo cross-linking and chromatin
immunoprecipitation (ChIP) assay, we show that
Rad26p, a yeast homologue of human CSB with a
DNA-dependent ATPase activity, is recruited to the sites
of 4NQO-induced DNA lesions at the coding sequences
of the active genes with the help of RNA polymerase II
and histone H3 lysine 36 (H3 K36) methylation in
Saccharomyces cerevisae. Such targeting of Rad26p
confers it to be a TC-NER-speciﬁc factor, and stimulates
its recognition of DNA lesions at the active genes, even-
tually leading to a faster TC-NER as compared to rela-
tively slow GG-NER.
MATERIALS AND METHODS
Plasmids
The plasmids, pFA6a-13Myc-KanMX6 and pFA6a-3HA-
His3MX6 (50) were used for genomic tagging of the
proteins of interest by myc and HA epitopes, respectively.
The plasmid pRS416 was used in the PCR-based gene
disruption.
Yeast strains
Yeast strain harboring temperature-sensitive (ts) mutation
in RPB1 was obtained from the Young laboratory
(Richard A. Young, MIT). Multiple myc-epitope tags
were added to the original chromosomal loci of RPB1,
RAD26 and RAD3 in W303a to generate ZDY4
(Rpb1p-myc, KAN), ZDY2 (Rad26p-myc, KAN) and
ASY41 (Rad3p-myc, KAN) respectively. The strain,
ZDY17 (Rad26p-myc, KAN; rpb1-ts), was generated by
adding multiple myc-epitope tags at the C-terminal of
Rad26p in the rpb1-ts strain. Three HA-epitope tags
were added to the chromosomal locus of RPB3 in
ZDY2 and ZDY17 to generate SMY8 (Rad26p-myc,
KAN; Rpb3p-HA, HIS3) and SMY9 (Rad26p-myc,
KAN; Rpb3p-HA, HIS3; rpb1-ts), respectively. The
strains, SLY6A (Rad26p-myc, KAN; Dset1, URA3) and
SLY7 (Rad26p-myc, KAN; Dset2, URA3), were generated
by deleting the SET1 and SET2 genes, respectively,
in ZDY2.
Growth media
For the studies at the GAL genes, the wild-type yeast
strain carrying myc epitope-tagged Rad26p or Rpb1p
was grown in YPR (yeast extract-peptone plus 2%
raﬃnose) up to an OD600 (optical density at 600nm) of
0.8 at 30 C, and then transferred to YPG (yeast extract–
peptone plus 2% galactose) for 90min to induce GAL1
prior to 4NQO treatment. The 4NQO-treated cells were
grown in YPG for 20min at 30 C prior to formaldehyde
cross-linking. For rpb1-ts mutant and its wild-type equiv-
alent, yeast cells were grown in YPG up to an OD600 of
0.85 at 23 C, and then transferred to 37 C for 1h before
cross-linking. For the induction of INO1, yeast cells were
initially grown in synthetic complete medium (yeast
nitrogen base and complete amino acid mixture plus 2%
dextrose) containing 100mM inositol at 30 Cu pt oa n
OD600 of 0.45, and then switched to the same medium
without inositol for 4h prior to 4NQO treatment or
formaldehyde-based in vivo cross-linking. For the studies
at RPS5, the yeast strain carrying myc epitope-tagged
Rad26p was grown in YPD (yeast extract, peptone plus
2% dextrose) up to an OD600 of 1.0.
ChIP assay
The ChIP assay was performed as described previously
(51–53). Brieﬂy, yeast cells were treated with 1% formal-
dehyde, collected and resuspended in lysis buﬀer.
Following sonication, cell lysate (400ml lysate from
50ml of yeast culture) was precleared by centrifugation,
and then 100ml lysate was used for each immunopre-
cipitation. Immunoprecipitated protein–DNA complexes
were treated with protease K, the cross-links were
reversed, and DNA was puriﬁed. Immunoprecipitated
DNA was dissolved in 20ml TE 8.0 (10mM Tris–HCl
pH 8.0 and 1mM EDTA), and 1ml of immunoprecipitated
DNA was analyzed by PCR. PCR reactions contained
[a-
32P]dATP (2.5mCi for each 25ml reaction), and the
PCR products were detected by autoradiography after
separation on a 6% polyacrylamide gel. As a control,
‘input’ DNA was isolated from 5ml lysate without going
through the immunoprecipitation step, and dissolved in
100ml TE 8.0. To compare PCR signal arising from the
immunoprecipitated DNA with the input DNA, 1mlo f
input DNA was used in the PCR analysis. Serial dilutions
of input and IP DNAs were used to assess the linear range
of PCR ampliﬁcation as described previously (51). All the
PCR data presented in this article are within the linear
range of the PCR analysis.
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modiﬁed the above ChIP protocol as follows. A total of
800ml lysate was prepared from 100ml of yeast culture.
The 400ml lysate was used for each immunoprecipitation
(using 10ml of anti-HA or anti-myc antibody and 100ml
of protein A/G plus agarose beads from Santa Cruz
Biotechnology, Inc.), and immunoprecipitated DNA
sample was dissolved in 10ml TE 8.0 of which 1ml was
used for the PCR analysis. In parallel, the PCR analysis
for ‘input’ DNA was performed using 1ml DNA that was
prepared by dissolving puriﬁed DNA from 5ml lysate in
100ml TE 8.0.
All ChIP experiments were repeated multiple times, and
consistent results were obtained. The primer pairs used for
PCR analysis are presented in Table 1. Autoradiograms
were scanned and quantitated by the National Institutes
of Health image 1.62 program. Immunoprecipitated (IP)
DNAs were quantitated as the ratio of IP to input. The
input DNA was isolated from 5% of the lysate that was
used for immunoprecipitation in the normal ChIP assay.
In case of modiﬁed ChIP assay for analysis of the
recruitment of Rad26p to the gene loci, the input DNA
was prepared from 1.25% of the lysate that was used for
immunoprecipitation. A 1/100th of the input DNA was
used for the PCR analysis. A 1/20th and 1/10th of the
immunoprecipitated DNAs were used for the PCR
analysis in the normal and modiﬁed ChIP assays,
respectively.
DNA damage protocol
Yeast cells were grown to a desired OD600 as mentioned
above in growth media, and then a concentrated solution
of 4NQO in ethanol (0.4mg/ml) was added to the growing
yeast culture to a ﬁnal concentration of 4mg/ml. The
4NQO-treated cells were allowed to grow under inducible
conditions at 30 C for 20min, and then these cells were
processed for the ChIP analysis. To ensure maximum
damage, yeast cells were also treated with a ﬁnal concen-
tration of 16mg/ml 4NQO in YPR, and then allowed to
grow for 10min at 30 C.
Genomic DNA preparation
The genomic DNA was extracted from 5ml of 4NQO-
treated yeast cells. Brieﬂy, the harvested cells were sus-
pended in 200ml lysis buﬀer (50mM HEPES, pH 7.5;
140mM NaCl; 1mM EDTA; 1% Triton X-100; and
0.1% Na-deoxycholate) with 200ml volume-equivalent of
glass beads, and then were vortexed for 30min at 4 C
using a Tommy vortexer. The whole-cell extract (WCE)
was collected by punching a hole at the bottom of the
eppendorf tube, and then was partitioned with 200mlo f
phenol:chloroform:isoamylalcohol. The aqueous phase
following phenol:chloroform extraction was treated with
ethanol to precipitate genomic DNA.
The genomic DNA was analyzed for 4NQO-induced
DNA damage at GAL1, GAL7, GAL10 and INO1
loci, using the primer pairs listed for the whole genes in
Table 1. The PCR products were analyzed by agarose gel
electrophoresis and ethidium bromide staining. The PCR
signals were quantitated by National Institutes of Health
image 1.62 program.
WCE preparation and western blot analysis
For analysis of global level of Rad26p in the SET2
deletion mutant and its isogenic wild-type equivalent,
the yeast strains expressing myc epitope-tagged Rad26p
were grown in 20ml YPD up to an OD600 of 1.0, and
then harvested cells were lysed to prepare the WCE fol-
lowing the protocol as described previously for the ChIP
assay (51–53). To analyze the global level of Rad26p in the
rpb1-ts mutant and wild-type strains, yeast cells were
grown in YPD up to an OD600 of 0.85 at 23 C, and
then shifted to 37 C for 1h before harvesting to prepare
WCE. The WCE was run on SDS–polyacrylamide gel,
and then analyzed by western blot assay. The anti-myc
antibody (9E10; Santa Cruz Biotechnology, Inc.) was
used for western blot analysis.
Table 1. The primers used in this study
GAL1 (UAS): 50-CGCTTAACTGCTCATTGCTATATTG-30
50-TTGTTCGGAGCAGTGCGGCGC-30
GAL1 (Core): 50-ATAGGATGATAATGCGATTAGTTTTT
TAGCCTT-30
50-GAAAATGTTGAAAGTATTAGTTAAAG
TGGTTATGCA-30
GAL1 (ORF1): 50-CAGTGGATTGTCTTCTTCGGCCGC-30
50-GGCAGCCTGATCCATACCGCCATT-30
GAL1 (ORF2): 50-CAGAGGGCTAAGCATGTGTATTCT-30
50-GTCAATCTCTGGACAAGAACATTC-30
GAL7 (Core): 50-CTATGTTCAGTTAGTTTGGCTAGC-30
50-TTGATGCTCTGCATAATAATGCCC-30
GAL7 (ORF): 50-TGAGACCTTGGTCATTTCAAAGAAG-30
50-ATGGATACCCATTGAGTATGGGAAA-30
GAL10 (Core): 50-GCTAAGATAATGGGGCTCTTTACAT-30
50-TTTCACTTTGTAACTGAGCTGTCAT-30
GAL10 (ORF): 50-TTAATGCGAATCATAGTAGTATCGG-30
50-TTACCAATAGATCACCTGGAAATTC-30
INO1 (UAS): 50-TATGAAATACGTGCCGGTGTTCCGG-30
50-TCAATATTCTGGGAAAGAAGGATGA-30
INO1 (Core): 50-TTCACATGGAGCAGAGAAAGCGCA-30
50-GGATAAAACTAACATTAGGAAC
CCGAC-30
INO1 (ORF1): 50-TGCCCATGGTTAGCCCAAACGACTT-30
50-AAGGAAGAGGCTTCACCAAGGACA-30
INO1 (ORF2): 50-GTTCTGTCATAGATGACATCATCG-30
50-GGTTATGGCCACCTAACATCAACTC-30
RPS5 (UAS): 50-AGAAACAATGAACAGCCTTGAG
TTCTC-30
50-GCAGGGCCATTCTCATCTGA-30
RPS5 (Core): 50-GGCCAACTTCTACGCTCACGTTAG-30
50-CGGTGTCAGACATCTTTGGAATGGTC-30
RPS5 (ORF): 50-AGGCTCAATGTCCAATCATTGAAAG-30
50-CAACAACTTGGATTGGGTTTTGGTC-30
GAL1 (whole gene): 50-CGCTTAACTGCTCATTGCTATATTG-30
50-TTTTGTCCCTGTGTTTTAAAGTTT
GTGG-30
GAL7 (whole gene): 50-TCATACATTCTTAAATTGCTTTGCCT
CTCC-30
50-CTTACAAGCTGCATTGTATTCCTAA-30
GAL10 (whole gene): 50-TTGTTCGGAGCAGTGCGGCGC-30
50-AATTTTTGATGTCTCCATGGTGGTA-30
INO1 (whole gene): 50-TATGAAATACGTGCCGGTGTTCCGG-30
50-GGTTATGGCCACCTAACATCAACTC-30
ORF, open reading frame; ORF1, towards the 50-end of the ORF;
ORF2, towards the 30-end of the ORF; Core, core promoter; and
UAS, upstream activating sequence.
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The co-immunoprecipitation assay was performed as
described previously (54). Brieﬂy, the yeast strain
carrying HA-tagged Rpb3p and myc-tagged Rad26p was
grown in YPD up to an OD600 of 1.0, and then
cross-linked by formaldehyde. The WCE was prepared
by lysing and sonicating the cross-linked yeast cells as
described in the ChIP assay. Immunoprecipitation was
performed using an anti-HA antibody and protein A/G
plus agarose beads. An anti-FLAG was used as a
non-speciﬁc antibody. After immunoprecipitation, the
agarose beads were washed as in the ChIP assay. The
washed A/G plus agarose beads were boiled in the SDS–
PAGE loading buﬀer, and then the supernatant was used
for SDS–PAGE and western blot analysis. The anti-myc
antibody was used in the western blot analysis. For
DNAase treatment in the co-immunoprecipitation assay,
the WCE was treated with 50 U of DNAase I for 30min at
37 C in the presence of protease inhibitors prior to the
addition of antibody. For co-immunoprecipitation assay
in the rpb1-ts mutant strain, both the wild-type and
mutant strains were grown in YPD up to an OD600 of
0.85 at 23 C, and then switched to 37 C for 1h before
harvesting.
RESULTS
Rad26p associates with the coding sequences of active,
but not inactive, genes
To determine whether Rad26p is recruited to the active
gene in a DNA lesion-dependent or -independent manner,
we analyzed its association with an inducible yeast gene,
GAL1, in the absence of DNA lesions, using a ChIP assay.
The GAL1 expression is driven by the activator, Gal4p.
In raﬃnose-containing (non-inducing) growth medium,
Gal80p binds to the activation domain of Gal4p
(55–57), and hence prevents the formation of the PIC
assembly. Thus, the expression of GAL1 is switched oﬀ
in raﬃnose-containing growth medium. When the yeast
cells grown in raﬃnose-containing growth medium is
transferred to galactose-containing (inducing) growth
medium, Gal80p does not remain bound to the Gal4p
activation domain (56,57), and hence PIC is assembled
at the GAL1 core promoter (55,58,59), leading to the
expression of GAL1.
To perform the ChIP assay at GAL1, we tagged Rad26p
by myc-epitope at its chromosomal locus in the wild-type
strain, W303a. The functionality of myc-tagged Rad26p
was analyzed by the association of RNA polymerase II
with the GAL1 coding sequence as previous studies
(60,61) have implicated Rad26p in transcriptional elonga-
tion of GAL genes. We ﬁnd that the association of RNA
polymerase II with the GAL1 coding sequence is signiﬁ-
cantly decreased in Drad26 (Supplementary Figure S1),
consistent with previous studies (60,61). However, myc-
epitope tagging of Rad26p does not alter the association
of RNA polymerase II with the GAL1 coding sequence
(Supplementary Figure S1). Further, the initial growth
rate of the yeast strain following UV-irradiation was not
decreased by myc-epitope tagging of Rad26p as compared
to the strain containing untagged Rad26p (Supplementary
Figure S2). However, the deletion of RAD26 signiﬁcantly
slowed down the initial growth of the yeast strain follow-
ing UV-irradiation as compared to the wild type equiva-
lent (Supplementary Figure S3). Together, these results
support that myc-tagged Rad26p is functional in tran-
scription as well as in DNA repair. In fact, epitope-
tagged Rad26p has also been used previously in several
studies (62–67).
Using the strain bearing myc epitope-tagged Rad26p,
we performed the ChIP assay at the upstream activat-
ing sequence (UAS), core promoter, and two diﬀerent
regions (ORF1, towards the 50-end; and ORF2, towards
the 30-end) within the ORF of GAL1 (Figure 1A, bottom
panel), following the protocol as described in the
Materials and Methods section. Figure 1A (top panel)
shows that myc-tagged Rad26p was predominantly
associated with the coding sequence (ORF1 and ORF2)
of GAL1 under inducible conditions. An anti-HA was
used as a non-speciﬁc antibody, and thus, provided back-
ground signal in the ChIP assay. It is clear from the
Figure 1A that the ChIP signal arising from myc-tagged
Rad26 at the GAL1 coding sequence is much higher than
that of the anti-HA. Thus, Rad26p is speciﬁcally asso-
ciated with the coding sequence, but not promoter, of
the active GAL1 gene, even in the absence of the DNA
lesions.
The fact that Rad26p is associated with the GAL1
coding sequence under inducible conditions indicates the
requirement of active transcription for its association.
To test this possibility, we next analyzed the association
of Rad26p with the GAL1 coding sequence under non-
inducible conditions. We ﬁnd that, like RNA polymerase
II, Rad26p was also not associated with the GAL1 coding
sequence when GAL1 transcription was switched oﬀ under
non-inducible conditions (Figures 1B and C). Consistent
with this observation, we also ﬁnd that the association of
Rad26p with the GAL1 coding sequence was signiﬁcantly
impaired in the rpb1-ts mutant strain (Figure 1D).
However, such an impaired association of Rad26p could
be due to the loss of its stability in the rpb1-ts mutant
strain at non-permissive temperature. To test this possibil-
ity, we analyzed the global level of Rad26p in the RPB1
wild-type and ts mutant strains at permissive (23 C) as
well as non-permissive (37 C) temperatures. We ﬁnd that
the stability of Rad26p was not altered in the rpb1-ts
mutant strain while Rpb1p was signiﬁcantly degraded at
non-permissive temperature (Figure 1E). The level of TBP
was monitored as a loading control, and it was unchanged
(Figure 1E). Thus, RNA polymerase II or active transcrip-
tion plays an important role in association of Rad26p with
the GAL1 coding sequence.
Since Rad26p and RNA polymerase II were associated
with the GAL1 coding sequence, it seems likely that
Rad26p might be associated with RNA polymerase II
either directly or indirectly during transcriptional elonga-
tion. To test this possibility, we analyzed the association of
Rad26p with RNA polymerase II using a cross-linking-
based co-immunoprecipitation assay as described pre-
viously (54). In this direction, we generated a strain
1464 Nucleic Acids Research, 2010,Vol.38, No. 5Figure 1. Rad26p is associated with the coding sequence but not promoter of the GAL1 gene in a transcription-dependent manner. (A) Top panel:
analysis of the recruitment of Rad26p at the UAS, core promoter, ORF of the GAL1 gene. The yeast strain expressing myc-tagged Rad26p was
grown in YPG up to an OD600 of 1.0 prior to cross-linking. The ChIP assay was performed as described in the Materials and Methods section.
Immunoprecipitation was performed using a mouse monoclonal antibody against the c-myc epitope-tag (9E10; Santa Cruz Biotechnology, Inc.).
An anti-HA (Santa Cruz Biotechnology, Inc.) was used as a non-speciﬁc antibody. Both the input and immunoprecipitated DNA samples were
analyzed by PCR. The dilution factors for input and immunoprecipitated DNA samples are mentioned in the modiﬁed ChIP protocol (see ‘Materials
and Methods’ section). The immunoprecipitated DNA was quantitated as the ratio of immunoprecipitate over the input in the autoradiogram. The
fold enrichment of Rad26p at the GAL1 coding sequence with respect to UAS is presented. IP, immunoprecipitate. Bottom panel: the PCR primer
pairs located at the UAS, core promoter, and towards the 50-(ORF1) and 30-(ORF2) ends of the ORF of the GAL1 gene. (B) RNA polymerase II
is associated with the coding sequence of the active GAL1 gene. The yeast strain was grown in raﬃnose (YPR)- or galactose (YPG)-containing
growth medium up to an OD600 of 1.0 prior to crosslinking. Immunoprecipitations were performed using a mouse monoclonal antibody 8WG16
(Covance) against the carboxy terminal domain of the largest subunit (Rpb1p) of RNA polymerase II. (C) Rad26p is associated with the ORF of
the active GAL1 gene. The fold enrichment of Rad26p at the GAL1 coding sequence in galactose-containing growth medium in comparison to
raﬃnose-containing growth medium is presented. (D) Rpb1p is essential for recruitment of Rad26p to the GAL1 coding sequence. (E) Analysis of the
global levels of Rad26p in the rpb1-ts and wild-type strains at the non-permissive temperature. The yeast strain expressing myc epitope-tagged
Rad26p were grown in YPD medium at permissive (23 C) and non-permissive (37 C) temperatures as discussed in the ‘Materials and Methods’
section. The WCE was run on SDS–polyacrylamide gel, and then analyzed by western blot assay. (F) Rad26p interacts with RNA polymerase II as
revealed by the co-immunoprecipitation assay. (G) Analysis of Rad26p association with RNA polymerase II in the rpb1-ts mutant using a
co-immunoprecipitation assay. (H) The co-immunoprecipitation assay as in panel G in the presence of DNAase. (I) Analysis of DNA digestion
as a control for the experiments presented in (H). PCR-ampliﬁed DNA was treated with DNAase for 30min at 37 C, and then was analyzed by
agarose gel electrophoresis.
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subunit of RNA polymerase II. Using this strain, we per-
formed the co-immunoprecipitation assay as schematically
shown in Figure 1F (top panel). An anti-Flag was used as
a non-speciﬁc antibody in this assay. Figure 1F (bottom
panel) shows the association of Rad26p with RNA
polymerase II. Such an association was signiﬁcantly
impaired in the rpb1-ts mutant strain (Figure 1G), thus
implying the association of Rad26p with structurally
and/or functionally intact RNA polymerase II, since
Rpb1p maintains the structural/functional integrity of
RNA polymerase II (47,68–72). Further, this association
is not mediated by DNA as the treatment of WCE with
DNAase did not alter the interaction of Rad26p with
RNA polymerase II (Figures 1H and I). However, we
cannot rule out the possibility that DNA might be
playing an important role to bring Rad26p and RNA
polymerase II in proximity prior to cross-linking.
Nonetheless, our data demonstrate that Rad26p is
associated with RNA polymerase II. However, whether
this association is either direct or indirect remains to be
elucidated. Consistent with our observations, Li and
Smerdon (73) have also demonstrated the genetic interac-
tion between Rad26p and RNA polymerase II.
Next, we asked whether Rad26p is associated with other
genes in a transcription-dependent manner. To address
this question, we analyzed the association of Rad26p
with the promoters and coding sequences of two other
inducible GAL genes, namely GAL7 and GAL10
(Figure 2A, right panel), under both inducible and
non-inducible conditions. We ﬁnd that Rad26p was
associated with the coding sequences but not promoters
of GAL7 and GAL10 under inducible conditions
(Figures 2A and B). Thus, like GAL1, the GAL7 and
GAL10 genes recruit Rad26p at their coding sequences
in a transcription-dependent manner. Likewise, Rad26p
was also found to be associated with the coding
sequence, but not promoter, of a diﬀerent class of
inducible gene, INO1, in a transcription-dependent
manner (Figure 2C). Similar association of Rad26p was
also observed at the constitutively active gene, RPS5
(Figure 2D). Taken together, our data presented in
Figures 1 and 2 demonstrate that Rad26p associates
with the coding sequences of the active genes, indicating
a possible role of Rad26p in transcriptional elongation.
Indeed, Lee et al. (60,61) have implicated Rad26p in the
positive regulation of transcriptional elongation.
The DNA lesion alone does not target the recruitment of
Rad26p in the absence of active transcription
In addition to its role in transcriptional elongation,
Rad26p has been implicated to recognize DNA lesions
in TC-NER for signaling recruitment of other NER
factors (45,74–82). However, it is not known whether
DNA lesion alone can be suﬃcient enough to recruit
Rad26p in the absence of active transcription. With this
view, we introduced DNA lesions by 4NQO at GAL1
when its transcription was switched oﬀ in raﬃnose-
containing growth medium. 4NQO interacts with DNA,
and forms bulky adducts primarily with guanine bases and
to a lesser extent with adenine bases. These bulky adducts
are removed by NER. Figure 3A shows the presence of
4NQO-induced DNA lesions at the GAL1 gene based on
signiﬁcant loss of the PCR signal, consistent with our
previous studies (47). We next asked whether Rad26p is
recruited to DNA lesions at GAL1 in the absence of active
transcription. In this direction, we analyzed the
recruitment of Rad26p at GAL1 in raﬃnose-containing
medium following 4NQO-treatment. Figure 3B shows
that the recruitment of Rad26p at the promoter as well
as coding sequence of GAL1 was not induced by DNA
lesions. Further, in raﬃnose-containing growth medium,
RNA polymerase II was not associated with GAL1
(Figure 1B). Thus, DNA lesion alone does not induce
the recruitment of Rad26p to GAL1 in the absence of
active transcription or RNA polymerase II.
To determine whether DNA lesions present at other
inactive genes can target Rad26p, we analyzed the
recruitment of Rad26p to GAL7 and GAL10 in
raﬃnose-containing growth medium following 4NQO-
treatment. Figure 3A shows the presence of 4NQO-
induced DNA lesions at GAL7 and GAL10 based on the
loss of PCR signal, consistent with our previous studies
(47). However, 4NQO-induced DNA lesions at GAL7
and GAL10 do not induce the recruitment of Rad26p in
raﬃnose-containing growth medium (Figures 3C and 3D).
Similarly, 4NQO-induced lesions at INO1 (Figure 3E) do
not trigger the recruitment of Rad26p in the absence of
active transcription (Figure 3F). Collectively, our data
presented in Figures 3A–F demonstrate that DNA
lesions alone do not induce the recruitment of Rad26p
in the absence of active transcription.
To determine whether severe DNA damage at higher
4NQO concentration can induce the recruitment of
Rad26p at the inactive coding sequence, we treated yeast
cells carrying myc-tagged Rad26p in raﬃnose-containing
growth medium with 4NQO at a ﬁnal concentration of
16mg/ml for 10min. Then, we analyzed the recruitment
of Rad26p to GAL1. Figure 3G shows that the whole
GAL1 gene was severely damaged following 4NQO treat-
ment. However, the smaller regions (ChIP PCR regions
such as GAL1-Core, GAL1-ORF1 and GAL1-ORF2 with
an average size of  150bp) of GAL1 were not signiﬁcantly
damaged, thus allowing the ChIP PCR as schematically
shown in Figure 1A (bottom panel). Figure 3H shows
that even severe damage at GAL1 does not induce the
recruitment of Rad26p in the absence of active
transcription.
Although our data demonstrate that DNA lesions
present at the inactive gene cannot induce the recruitment
of Rad26p, it is quite possible that 4NQO might be
generating lesions at or around the ChIP PCR region
( 150bp) in a small fraction of cells. Such a possibility
could lead to our inability to detect the recruitment
of Rad26p at the inactive coding sequence in response to
4NQO-induced DNA damage. Furthermore, the presence
of DNA lesion within the ChIP PCR region will inhibit
PCR, and thus, the recruitment of Rad26p to the lesion
within the ChIP PCR region would not be detected.
However, our data in Figure 4B show that PCR signal
at the ChIP PCR region (i.e. GAL1-ORF1) is not
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the ChIP PCR region. This is consistent with our previous
study (47). However, the recruitment of Rad26p at the
DNA lesions around the ChIP PCR region can be
detected in the ChIP analysis (Figure 4C), since DNA
fragments of  500bp or less are generated by sonication
(Figure 4A) and signiﬁcant fractions ( 50%) of cells have
DNA lesions within 300–500bp fragments of the GAL1
coding sequence (Figure 4B). Thus, if Rad26p is recruited
within  500bp fragment around the ChIP PCR region of
Figure 2. Rad26p is associated with the coding sequences but not promoters of the genes in a transcription-dependent manner. (A) Rad26p is
associated with the coding sequences of the active GAL7 and GAL10 genes. The ChIP assay was performed as in Figure 1A. The fold enrichment of
Rad26p at the coding sequence in comparison to the core promoter is presented. (B) Rad26p is associated with the ORFs of GAL7 and GAL10 in a
transcription-dependent manner. The fold enrichment of Rad26p at the coding sequence in galactose-containing growth medium in comparison to
raﬃnose-containing growth medium is presented. (C) Rad26p is associated with the coding sequence of the INO1 gene in a transcription-dependent
manner. The yeast strain expressing myc-tagged Rad26p was induced for INO1 as described in the ‘Materials and Methods’ section. Primer pairs
located at the UAS, core promoter, two diﬀerent locations (ORF1 and ORF2) of ORF of INO1 (bottom panel) were used for the PCR analysis of
the immunoprecipitated DNA samples. +, induced stated; and  , repressed state. The ChIP assay was performed as in Figure 1A. The fold enrich-
ment of Rad26p at diﬀerent locations of INO1 under transcriptionally active conditions in comparison to inactive conditions is presented. (D)
Rad26p is associated with the coding sequence, but not promoter, of a constitutively active gene, RPS5. The yeast strain carrying myc epitope-tagged
Rad26p was grown in YPD up to an OD600 of 1.0 prior to cross-linking. The ChIP assay was performed as in Figure 1A. The fold enrichment of
Rad26p at the RPS5 coding sequence with respect to UAS is presented.
Nucleic Acids Research,2010, Vol.38, No. 5 1467Figure 3. The DNA lesion alone does not target the recruitment of Rad26p in the absence of active transcription. (A) Analysis of DNA damage
at the GAL1, GAL7 and GAL10 loci within the ﬁrst 20min of 4NQO treatment. The yeast cells were grown in YPR, and then treated with 4NQO
for 20min. The genomic DNA was prepared and was analyzed by PCR. (B) The DNA lesions at the GAL1 gene do not target the recruitment
of Rad26p in the absence of active transcription. The yeast strain carrying myc-tagged Rad26p was grown in YPR up to an OD600 of 1.0, and then
treated with 4NQO for 20min prior to cross-linking. The ChIP assay was carried out as in Figure 1A. The fold change of Rad26p ChIP signal at
GAL1 in 4NQO-treated cells in comparison to untreated cells under transcriptionally inactive conditions. The DNA lesions at the GAL10 (C) and
GAL7 (D) genes also do not target the recruitment of Rad26p in the absence of active transcription. (E) Analysis of DNA damage at the INO1 gene
within the ﬁrst 20min of 4NQO treatment. Yeast cells were grown in synthetic complete medium containing 100mM inositol at 30 Cu pt oa nO D 600
of 1.0, and then treated with 4NQO for 20min. The whole INO1 gene was ampliﬁed by PCR, using the speciﬁc primer pairs as mentioned in Table 1.
(F) The DNA lesions at the INO1 gene do not target the recruitment of Rad26p in the absence of active transcription. The yeast strain expressing
myc-tagged Rad26p was grown in the synthetic complete medium containing 100mM inositol at 30 Cu pt oa nO D 600 of 1.0, and then treated with
4NQO for 20min prior to cross-linking. (G) Analysis of DNA damage at the GAL1 locus within the ﬁrst 10min of 4NQO treatment at a concen-
tration of 16mg/ml. The yeast cells were grown in YPR and treated with 4NQO as in (A). The whole GAL1 locus, core promoter, ORF1 and ORF2
regions were ampliﬁed by PCR, using the speciﬁc primer pairs as mentioned in Table 1. (H) Analysis of the association of Rad26p with GAL1
following 4NQO treatment at the concentration of 16mg/ml in the absence of transcription. Yeast cells were grown in YPR. The ChIP assay was
performed as in Figure 1A. The fold change of Rad26p ChIP signal at GAL1 in 4NQO-treated cells in comparison to untreated cells under
transcriptionally inactive conditions.
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the ChIP assay as schematically shown in Figure 4C.
However, we do not observe the recruitment of Rad26p
to the GAL1-ORF1 in response to 4NQO-induced
DNA damage in raﬃnose-containing growth medium
(Figure 3B and H). Thus, DNA lesions alone do not
appear to recruit Rad26p in the absence of transcription.
However, it may be quite possible that the recruitment
of Rad26 to the site of DNA lesion may make the site
more vulnerable to sonication, which in turn could lead
to our inability to observe the Rad26p ChIP signal as
schematically shown in Figure 4C. In fact, we
observe the recruitment of Rad26p to the GAL1 coding
sequence following 4NQO-induced DNA damage in a
transcription-dependent manner (see below; Figure 5B
and C). Further, we observe the recruitment of Rad3p
to the active GAL1 coding sequence in response to
4NQO-induced DNA damage (see below; Figure 5D).
Therefore, the DNA lesion sites associated with Rad26p
do not seem to be more readily broken during chromatin
shearing than those not associated with Rad26p. This is
further supported by the fact that the association of
Figure 4. Analysis of DNA lesion in the GAL1 coding sequence. (A) Analysis of the size of DNA fragments in the ChIP assay. Yeast cells were
grown in YPR prior to cross-linking as in Figure 3B. The genomic DNA was isolated following sonication (7 times, 10s each) of WCE and was
analyzed by agarose gel electrophoresis. (B) Analysis of DNA damage at GAL1 with varying lengths of coding sequence. Yeast cells were grown,
cross-linked and sonicated as in (A). Cells were treated with 4NQO at a ﬁnal concentration of 4mg/ml as described in Figure 3A. DNA was
isolated and analyzed by PCR using speciﬁc primer pairs. PCR products with diﬀerent sizes were analyzed by 2% agarose gel electrophoresis.
(C) The schematic diagram for the analysis of Rad26p recruitment at the site of DNA lesion in the ChIP assay. The ‘star’ represents the site of DNA
lesion.
Nucleic Acids Research,2010, Vol.38, No. 5 1469Gal4p with the GAL1 UAS was not altered following
4NQO-induced DNA damage in our ChIP analysis
(Supplementary Figure S4).
Rad26p is recruited to the sites of DNA lesions at the
coding sequences of the active genes with the help
of RNA polymerase II
How does Rad26p get recruited to the site of DNA lesion
at the coding sequence of the active gene in TC-NER?
We show here that Rad26p is co-associated with RNA
polymerase II at the coding sequences of the active
genes (Figures 1 and 2). RNA polymerase II stalls when
it encounters the DNA lesion (24,31,32,36,38,41–46).
Further, we have recently demonstrated that elongating
RNA polymerase II is disassembled through the degra-
dation of its largest subunit at the coding sequences of
several active genes in response to DNA damage (47).
Based on these observations, we hypothesize that
elongating RNA polymerase II promotes the recruitment
of Rad26p to the site of damaged DNA followed by its
disassembly through degradation of its largest subunit.
According to this hypothesis, if elongating RNA
polymerase II delivers Rad26p to DNA lesion, Rad26p
would remain associated with the coding sequence even
after the disassembly of elongating RNA polymerase II
Figure 5. RNA polymerase II promotes the recruitment of Rad26p to the DNA lesions at the coding sequences of the active GAL1 and GAL10
genes. (A) Analysis of the association of RNA polymerase II with the GAL1 coding sequence in the presence and absence of 4NQO-induced DNA
damage. The yeast strain was grown in YPR up to an OD600 of 0.8 at 30 C, and then transferred to YPG for 90min to induce GAL1 prior to 4NQO
treatment for 20min. As a control, yeast cells were also grown under similar growth conditions without 4NQO treatment. These cells were used for
the ChIP assay to analyze the level of Rpb1p at the GAL1 ORF in 4NQO-treated (+) and untreated ( ) cells. The percentage of DNA
immunoprecipitated in the 4NQO-treated cells relative to that of the untreated cells is represented as ‘%IP of -4NQO’. (B) Analysis of Rad26p
recruitment towards the 50- and 30-ends of the GAL1 ORF in the presence and absence of 4NQO-induced DNA damage. The yeast strain carrying
myc-tagged Rad26p was grown and crosslinked as in (A). Immunoprecipitation was performed as in Figure 1A. (C) The ChIP experiments at the
GAL1 coding sequence using the strain that bears untagged Rad26p. An anti-myc antibody was used in the ChIP assay. (D) Analysis of Rad3p
recruitment at the GAL1 coding sequence following 4mg/ml 4NQO treatment. Immunoprecipitation was performed using the modiﬁed ChIP protocol
as described in the ‘Materials and Methods’ section. (E) Analysis of the association of Rad26p and RNA polymerase II with the GAL10 ORF.
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we analyzed the association of RNA polymerase II
(Rpb1p) and Rad26p with the GAL1 coding sequence at
20min following 4NQO-treatment in galactose-containing
growth medium. The 4NQO-treatment time was chosen
to be 20min based on our recent studies (47). Within
this 4NQO-treatment time, the association of RNA
polymerase II with the GAL1 ORF was signiﬁcantly
lost due to the disassembly of RNA polymerase II (47).
As a control, the association of RNA polymerase II and
Rad26p with the GAL1 coding sequence was also analyzed
without 4NQO-treatment. Figure 5A (left panel) shows
signiﬁcant loss of RNA polymerase II association with
the 50-end of the GAL1 coding sequence (ORF1) in
4NQO-treated cells as compared to that of the untreated
cells. Such a loss of RNA polymerase II association with
the GAL1 coding sequence has been attributed in our
recent studies (47) to the disassembly of elongating
RNA polymerase II through the degradation of its
largest subunit at the site of DNA lesion. Interestingly,
even when association of RNA polymerase II with
the GAL1 ORF1 was signiﬁcantly lost in 4NQO-treated
cells, Rad26p was retained at the GAL1 ORF1 (Figure 5B,
left panel). In contrast, Rad26p did not remain
signiﬁcantly associated with the GAL1 ORF in the
absence of RNA polymerase II or active transcription
when DNA was not damaged by 4NQO (Figure 1C and
D). Together, these observations support the retention of
Rad26p at the GAL1 coding sequence following the
disassembly of RNA polymerase II in response to
4NQO-induced DNA damage. As a negative control,
we show the absence of the Rad26p ChIP signal in the
strain bearing untagged Rad26p, using an anti-myc
antibody in the ChIP assay (Figure 5C). To verify as a
positive control whether DNA lesions in the active coding
sequence can also induce the recruitment of other DNA
repair factors, like Rad26p, we analyzed the recruitment
of Rad3p, a DNA repair factor with a helicase activity
that is involved in unwinding DNA duplex around the
lesion, to the active GAL1 coding sequence in response
to 4NQO-induced DNA damage. We ﬁnd that Rad3p is
recruited to the active GAL1 coding sequence in response
to 4NQO-induced DNA damage (Figure 5D). Thus, like
Rad26p, Rad3p is also recruited to the coding sequence of
active gene following 4NQO-induced DNA damage.
Next, we analyzed the association of RNA polymerase
II and Rad26p with the 30-end of the GAL1 coding
sequence following 20min 4NQO-treatment. Similar to
the 50-end, association of RNA polymerase II with the
30-end of the GAL1 coding sequence was lost in 4NQO-
treated cells (Figure 5A, right panel). However, like RNA
polymerase II, Rad26p was also not signiﬁcantly
associated with the 30-end of the GAL1 coding sequence
following 4NQO-treatment (Figure 5B, right panel). Such
an observation can be attributed to the fact that RNA
polymerase II did not reach the 30-end of the GAL1
coding sequence due to the presence of multiple DNA
lesions (within  1200 base pair fragment) ahead of the
30-end in the continuously 4NQO-treated cells as shown
in our previous studies (47). Thus, the association of
RNA polymerase II with the 30-end of the GAL1 coding
sequence was not observed in 4NQO-treated cells
(Figure 5A, right panel). Since RNA polymerase II did
not reach the 30-end of the GAL1 coding sequence, it did
not carry Rad26p. Thus, the association of Rad26p with
the 30-end of the GAL1 ORF was not observed in
4NQO-treated cells (Figure 5B, right panel). Together,
our data support the role of elongating RNA polymerase
II in recruitment of Rad26p to the site of DNA lesion.
To determine whether RNA polymerase II also
promotes the recruitment of Rad26p at the coding
sequences of other active genes in response to DNA
damage, we analyzed the association of Rad26p and
RNA polymerase II with the coding sequence of
another GAL gene, namely GAL10, in 4NQO-treated
cells. Figure 5E shows that the association of RNA
polymerase II with the GAL10 coding sequence was
signiﬁcantly decreased in 4NQO-treated cells, consistent
with our recent studies (47). However, the association of
Rad26p with the GAL10 coding sequence remained
unchanged (Figure 5E) even when the association of
RNA polymerase II was signiﬁcantly decreased in
4NQO-treated cells in comparison to that of the untreated
cells (Figure 5E). Thus, similar to the results obtained at
GAL1, we ﬁnd that Rad26p remained associated with the
GAL10 coding sequence following the disassembly of
elongating RNA polymerase II in response to 4NQO-
induced DNA damage. Next, we extended this study to
a diﬀerent inducible gene, INO1. We ﬁnd that the associ-
ation of Rpb1p with the INO1 coding sequence was
signiﬁcantly decreased in response to 4NQO-induced
DNA damage (Figure 6A), consistent with our previous
studies at GAL1, GAL7 and GAL10 (47). However, the
association of Rad26p with the 50-end of the INO1
coding sequence remained unchanged (Figure 6B and
C), similar to the results obtained at GAL1 and GAL10
(Figure 5B and E). The association of Rad26p with the
30-end of the INO1 coding sequence was moderately
decreased. Collectively, our data presented in Figures 5
and 6 demonstrate the retention of Rad26p at the
coding sequences of the active genes following the degra-
dation of Rpb1p in response to 4NQO-induced DNA
damage.
Histone H3K36 methylation enhances the association of
Rad26p with the active coding sequence
Our data demonstrate that RNA polymerase II or active
transcription is essential for association of Rad26p
with the coding sequences of the active genes either in
the presence or absence of DNA lesions. Next, we asked
whether RNA polymerase II plays a direct or indirect
role in recruitment of Rad26p. There can be at least
three diﬀerent scenarios: (i) elongating RNA polymerase
II evicts histones, and, subsequently, allows free DNA
to interact with Rad26p; (ii) Rad26p is associated with
the coding sequence in a RNA polymerase II-dependent
manner; and (iii) RNA polymerase II covalently modiﬁes
nucleosomal histones at the coding sequence indirectly by
recruiting histone modiﬁcation enzymes, and such modi-
ﬁcations may trigger association of Rad26p. We rule out
the ﬁrst possibility based on the fact that Rad26p was not
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region of GAL1 (83) (Figure 1A). Our data support the
second possibility, since the recruitment of Rad26p is
dependent on RNA polymerase II or active transcription
(Figure 1C–I). However, histone covalent modiﬁcations
that are mediated by RNA polymerase II or active tran-
scription at the coding sequence could also stimulate the
association of Rad26p. Thus, to test this third possibility,
we analyzed the roles of histone H3 K4 and K36 methyl-
ation in recruitment of Rad26p, since these covalent mod-
iﬁcations are mediated by elongating RNA polymerase II
or active transcription through Set1p and Set2p histone
methyltransferases, respectively. We ﬁnd that histone H3
K4 methylation or Set1p is dispensable for the recruitment
of Rad26p (Figure 7A). Interestingly, the recruitment of
Rad26p to GAL1 was signiﬁcantly impaired in the absence
of Set2p (Figure 7A) that is essential for histone H3 K36
methylation at the GAL1 coding sequence (Figure 7B and
C). However, such an impaired recruitment of Rad26p in
the absence of histone H3 K36 methylation could be due
to the reduced association of elongating RNA polymerase
II or the decreased stability of Rad26p. To test these
possibilities, we analyzed the association of Rpb1p with
the GAL1 coding sequence in the SET2 deletion mutant
and its isogenic wild-type equivalent. Figure 7D shows
that the association of Rpb1p with the GAL1 coding
sequence was modestly altered in the absence of histone
H3 K36 methylation or Set2p. In contrast, a dramatic
decrease of Rad26p recruitment was observed in Dset2
(Figure 7A). Further, the stabilities of Rad26p and
Rpb1p were not altered in Dset2 (Figure 7E). Thus, our
data demonstrate that histone H3 K36 methylation stim-
ulates the association of Rad26p with the coding sequence
of the active gene, and hence the factors (e.g. Ctk1p, RNA
polymerase II and general transcription factors) involved
in histone H3 K36 methylation are likely to alter indirectly
the recruitment of Rad26p.
Several studies (84–88) have implicated chromo, tudor,
PHD (plant homeodomain) ﬁnger, PWWP and MBT
(malignant brain tumor) domains in the recognition
of methylated-lysine residues on histones H3 and H4.
Therefore, it is likely that the stimulation of Rad26p
recruitment to the coding sequence of the active gene is
mediated by one of the above methylated-lysine recogni-
tion domains. To test this possibility, we performed the
bioinformatic analysis which revealed the absence of the
methylated-lysine recognition domain in Rad26p. Thus,
Rad26p seems to interact indirectly with methylated-K36
on histone H3. In support of this model, Krogan et al. (89)
have demonstrated the genetic interaction of Rad26p with
Sin3p which is a common component of Rpd3S (the
smaller version of a multi-subunit complex with histone
deacetylase activity) and Rpd3L (the larger version of a
multi-subunit complex with histone deacetylase activity).
Rpd3L is recruited to the promoter while Rpd3S associ-
ates with the coding sequence of the active gene to prevent
cryptic transcriptional initiation (90–93). The association
of Rpd3S with the coding sequence depends on histone
H3K36 methylation (90–93). Further, Li et al. (94) have
demonstrated the requirement of a combination of the
PHD ﬁnger and chromo domain of the speciﬁc Rco1p
and Eaf3p components of Rpd3S for its interaction with
methylated-K36 on histone H3. Thus, histone H3 K36
methylation appears to exert its stimulatory role in recruit-
ment of Rad26p via the interaction of Rad26p with the
Sin3p component of Rpd3S. However, such a model
remains to be elucidated.
DISCUSSION
TC-NER and GG-NER fundamentally follow similar
mechanisms except the recognition step of DNA lesion.
Figure 6. RNA polymerase II promotes the recruitment of Rad26p to
the site of DNA lesion at the coding sequence of the active INO1 gene.
(A) Analysis of association of RNA polymerase II with the INO1
coding sequence in the presence and absence of 4NQO-induced
DNA damage. The INO1 gene was induced prior to 4NQO treatment
(4mg/ml) for 20min as described in the ‘Materials and Methods’
section. As a control, yeast cells were also grown under similar
growth conditions without 4NQO treatment. These cells were used
for the ChIP assay to analyze the level of Rpb1p at the INO1 ORF
in 4NQO-treated (+) and untreated ( ) cells. (B) Analysis of the
recruitment of Rad26p towards the 50- and 30-ends (ORF1 and
ORF2, respectively) of the INO1 ORF in the presence and absence
of the 4NQO-induced DNA damage. The yeast strain carrying
myc-tagged Rad26p was grown and cross-linked as in (A).
Immunoprecipitation was performed as in Figure 1A. (C) The data
of the (A and B) were plotted in the form of a histogram.
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(A) Histone H3K36 methylation stimulates the recruitment of Rad26p to the coding sequence of the active GAL1 gene. The deletion mutants of
SET1 and SET2, and wild-type strains were grown in YPR up to an OD600 of 0.8 at 30 C, and then transferred to YPG for 90min to induce GAL1
prior to cross-linking. The immunoprecipitations were performed as described in Figure 1A. The normalized occupancies of Rad26p at the GAL1
ORF in the wild-type and deletion mutant strains were plotted in the form of a histogram. (B) Histone H3 associated with the coding sequence of the
active GAL1 gene is methylated on K36. Yeast cells were grown and cross-linked as in (A). Immunoprecipitation was performed using an
anti-H3K36me3 antibody (Abcam-ab9050) as described for normal ChIP assay (see ‘Materials and Methods’ section). (C) Set2 is essential for
histone H3 K36 methylation. The yeast strains were grown in YPG up to an OD600 prior to cross-linking. (D) Analysis of the association of RNA
polymerase II with the GAL1 coding sequence in the absence of histone H3 K4/36 methylation. The wild-type and deletion mutant strains were
grown and crosslinked as in (A). The immunoprecipitations were performed as in Figure 1B. The normalized occupancies of RNA polymerase II
(Rpb1p) at the GAL1 ORF in the presence and absence of histone H3 K4/36 methylation were plotted in the form of a histogram. (E) Analysis of the
global levels of Rad26p and Rpb1p in the wild-type and SET2 deletion mutant strains. Both the wild-type and mutant strains were grown as in (A)
for western blot analysis. An anti-myc antibody was used against myc-tagged Rad26 in the western blot analysis. A mouse monoclonal antibody
8WG16 (Covance) against the carboxy terminal domain of Rpb1p was used.
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kinetics of these two repair processes. Here, we show that
a TCR-speciﬁc factor, Rad26p, is recruited to the coding
sequence of the active genes in response to 4NQO-induced
DNA damage with the help of RNA polymerase II. On
the other hand, search for the damaged DNA at the
inactive genes or silent areas of the genome by Rad4p/
Rad23p (XPC/HHR23B in human) is not augmented by
elongating RNA polymerase II in GG-NER, since
elongating RNA polymerase II is not associated with the
inactive genes or silent areas of genome. Thus, our study
provides important information for the rapid rate of
TC-NER as compared to the slower GG-NER.
How is Rad26p recruited to the site of DNA lesion in
the presence of elongating RNA polymerase II? Our data
support that Rad26p is co-recruited with elongating RNA
polymerase II to the coding sequences of the active genes.
When RNA polymerase II stalls at the damaged DNA
site, it is disassembled through the degradation of its
largest subunit (47), leaving behind Rad26p to the site of
DNA lesion. This is consistent with previous biochemical
studies (95) that demonstrated the formation of a stable
complex of the human homologue of Rad26p with
elongating RNA polymerase II at the DNA pause site.
Here, we ﬁnd that elongating RNA polymerase
II-mediated histone H3K36 methylation also enhances
the association of Rad26p with the coding sequence of
the active gene. Further, following its pause at the
4NQO-induced damaged DNA site, elongating RNA
polymerase II might be changing its conformation
in vivo, and such a conformational change may help
Rad26p to interact more stably with DNA lesion.
Moreover, Rad26p might be recognizing DNA lesion at
the active gene in the presence of other, yet unknown,
factor(s) in vivo. Additionally, Rad26p might be eﬃciently
binding to the site of DNA lesion that has an altered con-
formation via the modulation of local base-stacking as
well as Watson–Crick hydrogen bonding as has been
structurally shown for the recognization of DNA lesion
by Rad4p (96). However, these possibilities of Rad26p
recognition of the DNA lesion in TC-NER remain to be
further investigated. Nonetheless, our study demonstrates
in vivo that Rad26p is recruited to 4NQO-induced DNA
lesion with the help of elongating RNA polymerase II, and
subsequently, RNA polymerase II is disassembled through
the degradation of its largest subunit. Once Rad26p is
recruited to the DNA lesion, it becomes independent on
the retention of RNA polymerase II. Similar results were
also obtained in case of UV-induced DNA lesions (Zhen
Duan and S.R.B., unpublished data). Thus, the mode of
Rad26p recognition of the lesion at the active genes seems
to be independent of the nature of the single strand DNA
damaging agents.
We ﬁnd the loss of RNA polymerase II at the coding
sequences, but not promoters, of the active GAL1, GAL7,
GAL10 and INO1 genes following 4NQO-induced DNA
damage. Such a loss of RNA polymerase II has been
attributed in our previous studies (47) to the disassembly
of elongating RNA polymerase II through the degrada-
tion of its largest subunit in response to 4NQO-induced
DNA damage in vivo. Consistent with our data in yeast,
a recent study (97) has also reported similar results in
living mammalian cells. Such disassembly of elongating
RNA polymerase II makes the damaged DNA accessible
to the DNA repair factors, since elongating RNA
polymerase II masks DNA lesion (40,98,99). Following
the disassembly of elongating RNA polymerase II,
Rad26p is left behind at the site of DNA lesion in vivo.
Is Rad26p recruited to the DNA lesion after the
disassembly of RNA polymerase II? We rule out this pos-
sibility, based on the fact that the DNA lesion at the
coding sequence of inactive gene fails to recruit Rad26p.
Thus, Rad26p is recruited to the site of DNA lesion prior
to the disassembly of elongating RNA polymerase II.
Following its recruitment, how does Rad26p participate
in DNA repair? Rad26p has a DNA-dependent ATPase
activity (100,101), and thus, upon its recruitment to the
site of DNA lesion, Rad26p might be altering the
chromatin structure around the damaged DNA, hence
facilitating the access of the DNA repair factors to the
site of DNA lesion. Indeed, a previous study (67) has
demonstrated the requirement of the chromatin remodel-
ing activity of Rad26p in DNA repair. Furthermore,
Rad26p might be contributing to the DNA repair
process by recruiting DNA repair factors through its
direct physical interaction. In support of this model,
several studies (79–81) have previously demonstrated the
physical interaction of Rad26p with Rad3p. Rad3p, in
turn, facilitates the incision of the DNA strand contain-
ing the lesion for subsequent steps of DNA repair (82).
Thus, Rad26p appears to facilitate DNA repair at the
coding sequences of the active genes by modulating the
chromatin structure to enhance recruitment of the DNA
repair factors and/or by directly interacting with the DNA
repair factor(s). However, this model remains to be
elucidated in vivo.
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